The pan European Stoxx 600 closed with a gain of 1.38 per cent. The UK's FTSE 100 gained 0.91 per cent, Germany's DAX climbed 1.55 per cent, and France's CAC 40 ended up 2.29 per cent, while ...

Some $279bn was wiped off the value of artificial intelligence giant Nvidia, as its shares dropped by 9.5pc, helping to pull ...

Hikma Pharmaceuticals rose as much as 3pc after Berenberg upgraded the British drugmaker’s shares to “buy” from “hold”. Watches of Switzerland Group jumped as much as 11.3pc to the top ...

The acquisition includes a commercial portfolio and pipeline of differentiated products, a manufacturing facility in ...

IBD is a chronic inflammation of the intestine characterised by severe stomach pain and diarrhoea affecting nearly 5 million people worldwide Riyadh – Hikma Pharmaceuticals KSA, announced the ...

Hikma Pharmaceuticals PLC HIK shares inched up 0.88% to £19.53 Monday, on what proved to be an all-around great trading session for the stock market, with the FTSE 100 Index UKX rising 0.06% to ...

Aug 27 (Reuters) - Drug companies Jazz (JAZZ.O), opens new tab and Hikma (HIK.L), opens new tab must face claims that they schemed to delay a generic version of Jazz’s blockbuster narcolepsy ...

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics ...

Hikma Pharmaceuticals in the US joined government officials and non-profit leaders today at a naloxone awareness and training event organized and hosted by Rep. Earl L. "Buddy" Carter of Georgia ...

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics ...